Jan 10 (Reuters) - Zai Lab Ltd 9688.HK:
ZAI LAB AND VERTEX ANNOUNCE STRATEGIC AGREEMENT TO DEVELOP AND COMMERCIALIZE POVETACICEPT IN MAINLAND CHINA, HONG KONG SAR, MACAU SAR, TAIWAN REGION AND SINGAPORE
ZAI LAB LTD - VERTEX TO RECEIVE UPFRONT PAYMENT, MILESTONE PAYMENTS, AND ROYALTIES
ZAI LAB LTD - TO HANDLE COMMERCIALIZATION ACTIVITIES FOR POVETACICEPT
Source text: nBw9wZyS4a
Further company coverage: 9688.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.